The biodMOX is a versatile screening workstation based on Increase Relative Optical Power (IROP) techonology, which relies on the interferometric optical signals of two interferometers as a biosensing method of quantifying the biomolecule accumulation or recognition in the sensing area. It is capable of working with low concentration of reagents and low sample volume per measurement in order to be used for screening in several immunoassays steps and methodologies. This label-free device complies an easy-to-use and cost-effective tool for immunoassays optimization in terms of performance, reagents cost, and measuring time.
Bio-optical detection was initially conceived by scientists from the research group of Optics, Photonics and Bio-Photonics within the Center of Biomedical Technology of the Universidad Politécnica de Madrid (UPM). From its founding in 2010 the company was focused primarily on R&D activities in collaboration with public and private institutions.
In 2017 BiOD was incorporated into BioHold with the explicit aim to expand its scope and commercialize services and products to the end-user market.